JP2007508393A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508393A5 JP2007508393A5 JP2006535599A JP2006535599A JP2007508393A5 JP 2007508393 A5 JP2007508393 A5 JP 2007508393A5 JP 2006535599 A JP2006535599 A JP 2006535599A JP 2006535599 A JP2006535599 A JP 2006535599A JP 2007508393 A5 JP2007508393 A5 JP 2007508393A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclohexanol
- ylethyl
- piperazin
- naphthyl
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- -1 methylenedioxy, benzyloxy Chemical group 0.000 claims 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 6
- 125000004423 acyloxy group Chemical group 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 5
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 3
- 150000001721 carbon Chemical group 0.000 claims 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000001041 indolyl group Chemical group 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 claims 3
- 125000001544 thienyl group Chemical group 0.000 claims 3
- RSILIVTXIUSPEG-UHFFFAOYSA-N 1-(2-piperazin-1-yl-1-pyridin-3-ylethyl)cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1C=NC=CC=1)C1(O)CCCCC1 RSILIVTXIUSPEG-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 2
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 claims 2
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 claims 2
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 229940124530 sulfonamide Drugs 0.000 claims 2
- 150000003456 sulfonamides Chemical class 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 150000003462 sulfoxides Chemical class 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- JPVRAQXTYGKFHO-UHFFFAOYSA-N 1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cyclobutan-1-ol Chemical compound C1CNCCN1CC(C=1C2=CC=CC=C2C=CC=1)C1(O)CCC1 JPVRAQXTYGKFHO-UHFFFAOYSA-N 0.000 claims 1
- HKAACCZKGRMTRU-UHFFFAOYSA-N 1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cycloheptan-1-ol Chemical compound C1CNCCN1CC(C=1C2=CC=CC=C2C=CC=1)C1(O)CCCCCC1 HKAACCZKGRMTRU-UHFFFAOYSA-N 0.000 claims 1
- RUYSZTQZJFNBIF-UHFFFAOYSA-N 1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1C2=CC=CC=C2C=CC=1)C1(O)CCCCC1 RUYSZTQZJFNBIF-UHFFFAOYSA-N 0.000 claims 1
- SBUROEVBOPDOGG-UHFFFAOYSA-N 1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cyclooctan-1-ol Chemical compound C1CNCCN1CC(C=1C2=CC=CC=C2C=CC=1)C1(O)CCCCCCC1 SBUROEVBOPDOGG-UHFFFAOYSA-N 0.000 claims 1
- TWUKOCVCTOFCJM-UHFFFAOYSA-N 1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cyclopentan-1-ol Chemical compound C1CNCCN1CC(C=1C2=CC=CC=C2C=CC=1)C1(O)CCCC1 TWUKOCVCTOFCJM-UHFFFAOYSA-N 0.000 claims 1
- GTHMYYQEPTVKHM-UHFFFAOYSA-N 1-(1-naphthalen-2-yl-2-piperazin-1-ylethyl)cyclobutan-1-ol Chemical compound C1CNCCN1CC(C=1C=C2C=CC=CC2=CC=1)C1(O)CCC1 GTHMYYQEPTVKHM-UHFFFAOYSA-N 0.000 claims 1
- HTTUNNQBNOUDMP-UHFFFAOYSA-N 1-(1-naphthalen-2-yl-2-piperazin-1-ylethyl)cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1C=C2C=CC=CC2=CC=1)C1(O)CCCCC1 HTTUNNQBNOUDMP-UHFFFAOYSA-N 0.000 claims 1
- MGCWVDDXPPKNQT-UHFFFAOYSA-N 1-(2-piperazin-1-yl-1-quinolin-3-ylethyl)cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1C=C2C=CC=CC2=NC=1)C1(O)CCCCC1 MGCWVDDXPPKNQT-UHFFFAOYSA-N 0.000 claims 1
- KHYNNQYNYMSTIB-HNNXBMFYSA-N 1-[(1r)-1-(5-chlorothiophen-3-yl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexan-1-ol Chemical compound C1CN(C)CCN1C[C@H](C1(O)CCCCC1)C1=CSC(Cl)=C1 KHYNNQYNYMSTIB-HNNXBMFYSA-N 0.000 claims 1
- KHYNNQYNYMSTIB-OAHLLOKOSA-N 1-[(1s)-1-(5-chlorothiophen-3-yl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexan-1-ol Chemical compound C1CN(C)CCN1C[C@@H](C1(O)CCCCC1)C1=CSC(Cl)=C1 KHYNNQYNYMSTIB-OAHLLOKOSA-N 0.000 claims 1
- IFCHBQFBWRMERT-UHFFFAOYSA-N 1-[1-(1-benzothiophen-2-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1SC2=CC=CC=C2C=1)C1(O)CCCCC1 IFCHBQFBWRMERT-UHFFFAOYSA-N 0.000 claims 1
- DRAQRLXEPIYYIE-UHFFFAOYSA-N 1-[1-(1-benzothiophen-3-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1C2=CC=CC=C2SC=1)C1(O)CCCCC1 DRAQRLXEPIYYIE-UHFFFAOYSA-N 0.000 claims 1
- UIOCALWWKYWNPJ-UHFFFAOYSA-N 1-[1-(1-methylindol-3-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C12=CC=CC=C2N(C)C=C1C(C1(O)CCCCC1)CN1CCNCC1 UIOCALWWKYWNPJ-UHFFFAOYSA-N 0.000 claims 1
- ATPVGUAENJWZBH-UHFFFAOYSA-N 1-[1-(1h-indol-3-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol;dihydrochloride Chemical compound Cl.Cl.C1CNCCN1CC(C=1C2=CC=CC=C2NC=1)C1(O)CCCCC1 ATPVGUAENJWZBH-UHFFFAOYSA-N 0.000 claims 1
- TVEJRNDJZBJGNP-UHFFFAOYSA-N 1-[1-(2-chlorothiophen-3-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C1=C(SC=C1)Cl)C1(O)CCCCC1 TVEJRNDJZBJGNP-UHFFFAOYSA-N 0.000 claims 1
- FOCUTFWDGVSLBZ-UHFFFAOYSA-N 1-[1-(4-bromothiophen-2-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1SC=C(Br)C=1)C1(O)CCCCC1 FOCUTFWDGVSLBZ-UHFFFAOYSA-N 0.000 claims 1
- LFLGWUQIVASPOV-UHFFFAOYSA-N 1-[1-(5-bromothiophen-2-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1SC(Br)=CC=1)C1(O)CCCCC1 LFLGWUQIVASPOV-UHFFFAOYSA-N 0.000 claims 1
- HHPPFFZXAIACRT-UHFFFAOYSA-N 1-[1-(5-chloro-1-benzothiophen-3-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1C2=CC(Cl)=CC=C2SC=1)C1(O)CCCCC1 HHPPFFZXAIACRT-UHFFFAOYSA-N 0.000 claims 1
- QVVYUPDVPHVIPQ-UHFFFAOYSA-N 1-[1-(5-chlorothiophen-2-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1SC(Cl)=CC=1)C1(O)CCCCC1 QVVYUPDVPHVIPQ-UHFFFAOYSA-N 0.000 claims 1
- KHYNNQYNYMSTIB-UHFFFAOYSA-N 1-[1-(5-chlorothiophen-3-yl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexan-1-ol Chemical compound C1CN(C)CCN1CC(C1(O)CCCCC1)C1=CSC(Cl)=C1 KHYNNQYNYMSTIB-UHFFFAOYSA-N 0.000 claims 1
- SRKHUCZOFIQCSE-UHFFFAOYSA-N 1-[1-(5-chlorothiophen-3-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1CNCCN1CC(C=1C=C(Cl)SC=1)C1(O)CCCCC1 SRKHUCZOFIQCSE-UHFFFAOYSA-N 0.000 claims 1
- XSPHHKRJUKVQPK-UHFFFAOYSA-N 1-[1-(5-methoxy-1-benzothiophen-3-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C12=CC(OC)=CC=C2SC=C1C(C1(O)CCCCC1)CN1CCNCC1 XSPHHKRJUKVQPK-UHFFFAOYSA-N 0.000 claims 1
- MOVFDALBQXQPCO-UHFFFAOYSA-N 1-[1-(6-methoxynaphthalen-2-yl)-2-(4-methylpiperazin-1-yl)ethyl]cyclohexan-1-ol Chemical compound C1=CC2=CC(OC)=CC=C2C=C1C(C1(O)CCCCC1)CN1CCN(C)CC1 MOVFDALBQXQPCO-UHFFFAOYSA-N 0.000 claims 1
- ZCTXXQHWWSHIAT-UHFFFAOYSA-N 1-[1-(6-methoxynaphthalen-2-yl)-2-piperazin-1-ylethyl]cyclohexan-1-ol Chemical compound C1=CC2=CC(OC)=CC=C2C=C1C(C1(O)CCCCC1)CN1CCNCC1 ZCTXXQHWWSHIAT-UHFFFAOYSA-N 0.000 claims 1
- VQLFVTXUDZOIJR-UHFFFAOYSA-N 1-[2-(4-aminopiperidin-1-yl)-1-(5-chlorothiophen-3-yl)ethyl]cyclohexan-1-ol Chemical compound C1CC(N)CCN1CC(C1(O)CCCCC1)C1=CSC(Cl)=C1 VQLFVTXUDZOIJR-UHFFFAOYSA-N 0.000 claims 1
- VCQQAKXMXUWGRX-UHFFFAOYSA-N 1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-1-ylethyl]cyclobutan-1-ol Chemical compound C1CN(C)CCN1CC(C1(O)CCC1)C1=CC=CC2=CC=CC=C12 VCQQAKXMXUWGRX-UHFFFAOYSA-N 0.000 claims 1
- IIZCNPUTDHQHLU-UHFFFAOYSA-N 1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-1-ylethyl]cycloheptan-1-ol Chemical compound C1CN(C)CCN1CC(C1(O)CCCCCC1)C1=CC=CC2=CC=CC=C12 IIZCNPUTDHQHLU-UHFFFAOYSA-N 0.000 claims 1
- TXPSUDIPBNUSFB-UHFFFAOYSA-N 1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-1-ylethyl]cyclooctan-1-ol Chemical compound C1CN(C)CCN1CC(C1(O)CCCCCCC1)C1=CC=CC2=CC=CC=C12 TXPSUDIPBNUSFB-UHFFFAOYSA-N 0.000 claims 1
- RLFLWGGBHHIWAO-UHFFFAOYSA-N 1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-1-ylethyl]cyclopentan-1-ol Chemical compound C1CN(C)CCN1CC(C1(O)CCCC1)C1=CC=CC2=CC=CC=C12 RLFLWGGBHHIWAO-UHFFFAOYSA-N 0.000 claims 1
- CBJUVETXAUPVLT-UHFFFAOYSA-N 1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-2-ylethyl]cyclohexan-1-ol Chemical compound C1CN(C)CCN1CC(C1(O)CCCCC1)C1=CC=C(C=CC=C2)C2=C1 CBJUVETXAUPVLT-UHFFFAOYSA-N 0.000 claims 1
- JTIUTIFUOYQNPY-UHFFFAOYSA-N 1-methyl-4-(1-naphthalen-2-yl-2-piperazin-1-ylethyl)piperidin-4-ol Chemical compound C1CN(C)CCC1(O)C(C=1C=C2C=CC=CC2=CC=1)CN1CCNCC1 JTIUTIFUOYQNPY-UHFFFAOYSA-N 0.000 claims 1
- YEKKRPAWNGTFDW-UHFFFAOYSA-N 3-ethyl-1-(4-methylpiperazin-1-yl)-2-naphthalen-1-ylpentan-3-ol Chemical compound C=1C=CC2=CC=CC=C2C=1C(C(O)(CC)CC)CN1CCN(C)CC1 YEKKRPAWNGTFDW-UHFFFAOYSA-N 0.000 claims 1
- CIFVSZAKDRBSML-UHFFFAOYSA-N 3-ethyl-2-naphthalen-1-yl-1-piperazin-1-ylpentan-3-ol Chemical compound C=1C=CC2=CC=CC=C2C=1C(C(O)(CC)CC)CN1CCNCC1 CIFVSZAKDRBSML-UHFFFAOYSA-N 0.000 claims 1
- UIHCCWOFJVGABZ-UHFFFAOYSA-N 4-ethyl-1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cyclohexan-1-ol Chemical compound C1CC(CC)CCC1(O)C(C=1C2=CC=CC=C2C=CC=1)CN1CCNCC1 UIHCCWOFJVGABZ-UHFFFAOYSA-N 0.000 claims 1
- ZXYZOEXRHXBRRJ-UHFFFAOYSA-N 4-ethyl-1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-1-ylethyl]cyclohexan-1-ol Chemical compound C1CC(CC)CCC1(O)C(C=1C2=CC=CC=C2C=CC=1)CN1CCN(C)CC1 ZXYZOEXRHXBRRJ-UHFFFAOYSA-N 0.000 claims 1
- WTOQYAIYLYXZLA-UHFFFAOYSA-N 4-methyl-1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cyclohexan-1-ol Chemical compound C1CC(C)CCC1(O)C(C=1C2=CC=CC=C2C=CC=1)CN1CCNCC1 WTOQYAIYLYXZLA-UHFFFAOYSA-N 0.000 claims 1
- DMPPVLSNDSVJMF-UHFFFAOYSA-N 4-methyl-1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-1-ylethyl]cyclohexan-1-ol Chemical compound C1CC(C)CCC1(O)C(C=1C2=CC=CC=C2C=CC=1)CN1CCN(C)CC1 DMPPVLSNDSVJMF-UHFFFAOYSA-N 0.000 claims 1
- VHNDPYFDLPRWNW-UHFFFAOYSA-N 4-tert-butyl-1-(1-naphthalen-1-yl-2-piperazin-1-ylethyl)cyclohexan-1-ol Chemical compound C1CC(C(C)(C)C)CCC1(O)C(C=1C2=CC=CC=C2C=CC=1)CN1CCNCC1 VHNDPYFDLPRWNW-UHFFFAOYSA-N 0.000 claims 1
- IUMMUJFGGVLQAX-UHFFFAOYSA-N 4-tert-butyl-1-[2-(4-methylpiperazin-1-yl)-1-naphthalen-1-ylethyl]cyclohexan-1-ol Chemical compound C1CN(C)CCN1CC(C1(O)CCC(CC1)C(C)(C)C)C1=CC=CC2=CC=CC=C12 IUMMUJFGGVLQAX-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 claims 1
- 230000001668 ameliorated effect Effects 0.000 claims 1
- 150000007514 bases Chemical class 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 230000000407 monoamine reuptake Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51081103P | 2003-10-14 | 2003-10-14 | |
| US56144704P | 2004-04-12 | 2004-04-12 | |
| US57005604P | 2004-05-11 | 2004-05-11 | |
| US10/963,064 US7419980B2 (en) | 2003-10-14 | 2004-10-12 | Fused-aryl and heteroaryl derivatives and methods of their use |
| PCT/US2004/033671 WO2005037283A1 (en) | 2003-10-14 | 2004-10-13 | Fused-aryl and heteroaryl derivatives and methods of their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007508393A JP2007508393A (ja) | 2007-04-05 |
| JP2007508393A5 true JP2007508393A5 (cg-RX-API-DMAC7.html) | 2007-12-13 |
Family
ID=34468484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006535599A Pending JP2007508393A (ja) | 2003-10-14 | 2004-10-13 | 縮合アリールおよびヘテロアリール誘導体およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7419980B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1673090A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007508393A (cg-RX-API-DMAC7.html) |
| AR (1) | AR046179A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004281734A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0415276A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2549733A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06003879A (cg-RX-API-DMAC7.html) |
| PA (1) | PA8615201A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200526603A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005037283A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US7414052B2 (en) * | 2004-03-30 | 2008-08-19 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US7772232B2 (en) * | 2004-04-15 | 2010-08-10 | Bristol-Myers Squibb Company | Quinazolinyl compounds as inhibitors of potassium channel function |
| EP1904059A2 (en) * | 2005-07-21 | 2008-04-02 | Wyeth a Corporation of the State of Delaware | Method for treating nervous system disorders and conditions |
| WO2007067575A2 (en) * | 2005-12-05 | 2007-06-14 | Wyeth | Process for preparing substituted aryl cycloalkanol derivatives |
| EP2089389A2 (en) | 2006-11-01 | 2009-08-19 | Bristol-Myers Squibb Company | Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity |
| WO2010016554A1 (ja) * | 2008-08-07 | 2010-02-11 | 武田薬品工業株式会社 | 環状アミン化合物 |
| EP2488020B1 (en) * | 2009-10-13 | 2016-12-14 | Wellstat Therapeutics Corporation | 3-substituted compounds for reducing uric acid |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3454554A (en) | 1960-10-14 | 1969-07-08 | Colgate Palmolive Co | Aminoalkyliminodibenzyl compounds |
| FR2035785A6 (cg-RX-API-DMAC7.html) * | 1969-03-28 | 1970-12-24 | Delalande Sa | |
| CS175831B1 (cg-RX-API-DMAC7.html) | 1974-12-17 | 1977-05-31 | ||
| IL56369A (en) | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| US4310524A (en) | 1980-04-11 | 1982-01-12 | Richardson-Merrell, Inc. | TCA Composition and method for rapid onset antidepressant therapy |
| PH18686A (en) | 1981-05-26 | 1985-08-29 | Merck & Co Inc | 1-(3 halo-2-pyridinyl) piperazine |
| US4535186A (en) | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| ZA864772B (en) | 1985-07-02 | 1987-02-25 | Merrell Dow Pharma | Novel chemical compounds |
| ZA885824B (en) | 1987-08-14 | 1989-04-26 | Merrell Dow Pharma | Novel antidepressants |
| US4826844A (en) | 1987-09-30 | 1989-05-02 | American Home Products Corporation | Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols |
| DE69105501T2 (de) | 1990-06-01 | 1995-04-13 | Merrell Dow Pharma | (+)-alpha-(2,3 dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinmethanol. |
| GB9021535D0 (en) | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US5502047A (en) | 1993-03-22 | 1996-03-26 | Kavey; Neil B. | Treatment for insomnia |
| GB9306103D0 (en) | 1993-03-24 | 1993-05-12 | Wyeth John & Brother Ltd | Piperazine derivatives |
| AU725556B2 (en) | 1996-03-25 | 2000-10-12 | Eli Lilly And Company | Method for treating pain |
| US6686353B1 (en) | 1996-05-20 | 2004-02-03 | Teijin Intellectual Property Center Limited | Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| JPH10218866A (ja) | 1997-02-07 | 1998-08-18 | Pola Chem Ind Inc | ドーパミン再取り込み阻害剤 |
| EA200000890A1 (ru) | 1998-03-02 | 2001-02-26 | Эли Лилли Энд Компани | Гидрохлорид флуоксетина для уменьшения "приливов" (приступообразных ощущений жара (при климактерическом синдроме)) |
| EP1905757A1 (en) | 1999-04-06 | 2008-04-02 | Sepracor Inc. | Derivatives of Venlafaxine and methods of preparing and using the same |
| EA011094B1 (ru) | 1999-07-01 | 2008-12-30 | Фармация Энд Апджон Компани | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения |
| US6949552B2 (en) * | 2000-06-27 | 2005-09-27 | Taisho Pharmaceutical Co., Ltd. | Remedial agent for anxiety neurosis or depression and piperazine derivative |
| BR0207157A (pt) | 2001-02-12 | 2004-02-17 | Wyeth Corp | Sal de succinato de o-desmetil-venlafaxina |
| WO2002078691A1 (en) | 2001-03-29 | 2002-10-10 | Eli Lilly And Company | Duloxetine for treatment of hot flashes |
| EP1266659A1 (en) | 2001-06-11 | 2002-12-18 | Pantarhei Bioscience B.V. | Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes |
| US20040259850A1 (en) | 2001-10-31 | 2004-12-23 | Alves Stephen E. | Method for treating or preventing symptoms of hormonal variation including hot flashes |
| US6602911B2 (en) | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
| CN1608050A (zh) * | 2001-12-21 | 2005-04-20 | 大正制药株式会社 | 哌嗪衍生物 |
| PL223471B1 (pl) | 2002-03-15 | 2016-10-31 | Cypress Bioscience Inc | Kompozycja farmaceutyczna zawierająca milnacypran do stosowania w leczeniu zespołu nadwrażliwości jelita grubego |
| TW200402289A (en) | 2002-05-17 | 2004-02-16 | Wyeth Corp | Methods of treating gastrointestinary and genitourinary pain disorders |
| MXPA05001705A (es) | 2002-08-14 | 2005-04-19 | Pharmacia & Upjohn Co Llc | Uso de reboxetina para el tratamiento de sofocos. |
| US20040180879A1 (en) | 2002-10-15 | 2004-09-16 | Deecher Darlene Coleman | Novel method of treating vasomotor symptoms |
| US7345096B2 (en) | 2002-10-15 | 2008-03-18 | Wyeth | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| US20040152710A1 (en) | 2002-10-15 | 2004-08-05 | Deecher Darlene Coleman | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
-
2004
- 2004-10-12 US US10/963,064 patent/US7419980B2/en not_active Expired - Fee Related
- 2004-10-13 TW TW093131005A patent/TW200526603A/zh unknown
- 2004-10-13 JP JP2006535599A patent/JP2007508393A/ja active Pending
- 2004-10-13 BR BRPI0415276-0A patent/BRPI0415276A/pt not_active IP Right Cessation
- 2004-10-13 MX MXPA06003879A patent/MXPA06003879A/es unknown
- 2004-10-13 WO PCT/US2004/033671 patent/WO2005037283A1/en not_active Ceased
- 2004-10-13 CA CA002549733A patent/CA2549733A1/en not_active Abandoned
- 2004-10-13 AU AU2004281734A patent/AU2004281734A1/en not_active Abandoned
- 2004-10-13 EP EP04794905A patent/EP1673090A1/en not_active Withdrawn
- 2004-10-14 PA PA20048615201A patent/PA8615201A1/es unknown
- 2004-10-14 AR ARP040103714A patent/AR046179A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005504126A5 (cg-RX-API-DMAC7.html) | ||
| JP2005053931A5 (cg-RX-API-DMAC7.html) | ||
| RU2000128658A (ru) | Тиенилазолилалкоксиэтанамны, их производные и их применение в качестве лекарственных средств | |
| JP2006526031A5 (cg-RX-API-DMAC7.html) | ||
| JP2009143956A5 (cg-RX-API-DMAC7.html) | ||
| JP2005505551A (ja) | Ｃｂ１受容体拮抗剤と脳内のドパミン作用性神経伝達を活性化する生成物を含む、パーキンソン病の治療のための組成物 | |
| EP2620432A3 (en) | Diarylhydantoin compounds | |
| JP2007508393A5 (cg-RX-API-DMAC7.html) | ||
| JP2009523760A5 (cg-RX-API-DMAC7.html) | ||
| MX2007012936A (es) | Derivados de dihidrobenzofurano y usos de los mismos. | |
| KR20080042098A (ko) | 신규 1-아릴-3-아자바이사이클로[3.1.0]헥산: 제조 방법 및신경 정신 질환 치료를 위한 용도 | |
| IL212230A (en) | Crystalline form of the hydrochloride salt of the compound 4 - [2- (2-fluorophenoxymethyl) phenyl] piperidine, its preparation, its pharmaceutical compositions and uses | |
| UA99447C2 (ru) | Способ получения силденафила | |
| JP2005536503A5 (cg-RX-API-DMAC7.html) | ||
| JP2004525184A5 (cg-RX-API-DMAC7.html) | ||
| JPH07505897A (ja) | フィブリノーゲンレセプター拮抗剤としての１‐ピペラジン酢酸誘導体 | |
| JP2010507590A5 (cg-RX-API-DMAC7.html) | ||
| WO2010011811A3 (en) | 3-(phenoxyphenylmethyl)pyrrolidine compounds | |
| JP2013514974A5 (cg-RX-API-DMAC7.html) | ||
| DE602004020730D1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
| WO2006057922A3 (en) | Niacin receptor agonists, compositions containing such compounds and methods of treatment | |
| WO2006057950A3 (en) | 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
| CN1049660C (zh) | 苯并吡喃化合物，它们的制备方法和含有它们的药物组合物 | |
| JP2012511558A5 (cg-RX-API-DMAC7.html) | ||
| JP2000507549A (ja) | α▲下２▼アドレナリン受容体アゴニスト活性を有する４―［（チエン―３―イル）メチル］イミダゾール誘導体 |